Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial

INTRODUCTION: Soluble urokinase plasminogen activator receptor (suPAR) is a prognostic and nonspecific biomarker associated with short-term mortality in emergency department (ED) patients. Therefore, the blood level of suPAR might be usable for identification of patients at high- and low risk, short...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Martin, Rasmussen, Line J. H., Kallemose, Thomas, Kjøller, Erik, Lind, Morten N., Ravn, Lisbet, Lange, Theis, Køber, Lars, Rasmussen, Lars S., Eugen-Olsen, Jesper, Iversen, Kasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458624/
https://www.ncbi.nlm.nih.gov/pubmed/30975178
http://dx.doi.org/10.1186/s13049-019-0621-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458624/
https://www.ncbi.nlm.nih.gov/pubmed/30975178
http://dx.doi.org/10.1186/s13049-019-0621-7

Ejemplares similares